RecruitingNCT04658290
Prevalence of Obstructive Sleep Apnea (OSA) and the Association With Cognitive Impairment
Sponsor
Chinese University of Hong Kong
Enrollment
500 participants
Start Date
Aug 29, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The study is aimed to carry out an epidemiology study investigating the prevalence of obstructive sleep apnea (OSA) and the association with cognitive impairment.
Eligibility
Min Age: 40 YearsMax Age: 74 Years
Inclusion Criteria1
- Have stability of at least 4 weeks on permitted medications (i.e. medications known not to affect sleep architecture or circadian rhythms).
Exclusion Criteria5
- Suspected dementia or a score of <24 on the mini-mental state examination
- A diagnosis of neurological disorders (e.g. Parkinson's Disease, Epilepsy, Multiple Sclerosis)
- Psychiatric disorders including current major depression; bipolar disorder; schizophrenia
- Other known clinically significant sleep disorders (e.g. narcolepsy)
- Been currently receiving CPAP or bi-level pressure for OSA
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04658290
Related Trials
Feasibility of Web-based Therapy Sessions
NCT075606961 location
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
NCT0523075820 locations
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
NCT0722676538 locations
Investigating Dynamic Interactions in Distributed Cognitive Control Networks
NCT059279741 location
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
NCT0722568647 locations